Har Grover with Scientus responded to an email I sent inquiring about the buccal product. This was 2 months plus ago. He wouldn't give a timeline but made it sound as if it is a ways off due to regulatory path needed. He did say substantial advances had been made. Of course we new this already from what Joe has shared on the calls.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links